民生銀行(600016.SH)擬委託CBD建設公司代建公司CBD總行辦公大樓項目土護降一體化工程
格隆匯 9 月 23日丨民生銀行(600016.SH)公佈,2020年9月23日,經公司第七屆董事會第二十二次臨時會議審議,同意委託北京商務中心區開發建設有限責任公司(“CBD建設公司”)代建公司CBD總行辦公大樓項目土護降一體化工程,費用預算為約9564.76萬元人民幣。
此筆業務發生後,大家人壽保險股份有限公司其關聯方在公司關聯交易審批總額合計205.96億元人民幣,佔公司上季末資本淨額比例為3.00%,佔公司最近一期經審計淨資產的比例為4.59%。根據《中國民生銀行股份有限公司關聯交易管理辦法》規定,此筆交易由董事會關聯交易控制委員會核後,提交董事會審議批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.